{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:01:16Z","timestamp":1787223676765,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12325-023-02558-2","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T11:02:27Z","timestamp":1690196547000},"page":"4358-4376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9835-0839","authenticated-orcid":false,"given":"Sari","family":"Hopson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-6839","authenticated-orcid":false,"given":"Liza R.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6738-4377","authenticated-orcid":false,"given":"Sahar","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1995-7094","authenticated-orcid":false,"given":"Robert","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-9782","authenticated-orcid":false,"given":"Laura","family":"McClung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-802X","authenticated-orcid":false,"given":"Silky","family":"Beaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"2558_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.","journal-title":"BMJ"},{"issue":"3","key":"2558_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","volume":"70","author":"TD Rachakonda","year":"2014","unstructured":"Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2558_CR3","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2558_CR4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496\u2013509.","journal-title":"N Engl J Med"},{"issue":"1","key":"2558_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12895-018-0072-2","volume":"18","author":"AW Armstrong","year":"2018","unstructured":"Armstrong AW, Foster SA, Comer BS, et al. Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization. BMC Dermatol. 2018;18(1):4.","journal-title":"BMC Dermatol"},{"issue":"6","key":"2558_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jamadermatol.2014.3593","volume":"151","author":"EA Brezinski","year":"2015","unstructured":"Brezinski EA, Dhillon JS, Armstrong AW. Economic burden of psoriasis in the United States: a systematic review. JAMA Dermatol. 2015;151(6):651\u20138.","journal-title":"JAMA Dermatol"},{"key":"2558_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.794229","volume":"8","author":"D Simon","year":"2021","unstructured":"Simon D, Watad A, Rodrigues-Manica S, et al. Editorial: early origins of psoriatic arthritis. Front Med (Lausanne). 2021;8: 794229.","journal-title":"Front Med (Lausanne)"},{"key":"2558_CR8","doi-asserted-by":"crossref","unstructured":"Ocampo DV, Gladman D. Psoriatic arthritis. F1000Res. 2019;8(F1000 Faculty Rev):1665.","DOI":"10.12688\/f1000research.19144.1"},{"issue":"10136","key":"2558_CR9","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","volume":"391","author":"DJ Veale","year":"2018","unstructured":"Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018;391(10136):2273\u201384.","journal-title":"Lancet"},{"issue":"10","key":"2558_CR10","first-page":"1918","volume":"32","author":"TM Madland","year":"2005","unstructured":"Madland TM, Apalset EM, Johannessen AE, et al. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol. 2005;32(10):1918\u201322.","journal-title":"J Rheumatol"},{"issue":"5","key":"2558_CR11","first-page":"1247","volume":"27","author":"M Shbeeb","year":"2000","unstructured":"Shbeeb M, Uramoto KM, Gibson LE, et al. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982\u20131991. J Rheumatol. 2000;27(5):1247\u201350.","journal-title":"J Rheumatol"},{"issue":"1","key":"2558_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/art.40726","volume":"71","author":"JA Singh","year":"2019","unstructured":"Singh JA, Guyatt G, Ogdie A, et al. Special Article: 2018 American College of Rheumatology\/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol. 2019;71(1):5\u201332.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"2558_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ad.2016.04.018","volume":"107","author":"R Burgos-Pol","year":"2016","unstructured":"Burgos-Pol R, Martinez-Sesmero JM, Ventura-Cerda JM, et al. The cost of psoriasis and psoriatic arthritis in 5 european countries: a systematic review. Actas Dermosifiliogr. 2016;107(7):577\u201390.","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"2558_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40744-019-0146-6","volume":"6","author":"PC Robinson","year":"2019","unstructured":"Robinson PC, Sengupta R, Siebert S. Non-radiographic axial spondyloarthritis (nr-axSpA): advances in classification, imaging and therapy. Rheumatol Ther. 2019;6(2):165\u201377.","journal-title":"Rheumatol Ther"},{"issue":"12","key":"2558_CR15","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3899\/jrheum.130588","volume":"40","author":"D Wallis","year":"2013","unstructured":"Wallis D, Haroon N, Ayearst R, et al. Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? J Rheumatol. 2013;40(12):2038\u201341.","journal-title":"J Rheumatol"},{"issue":"1","key":"2558_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0906-9","volume":"18","author":"R Burgos-Vargas","year":"2016","unstructured":"Burgos-Vargas R, Wei JC-C, Rahman MU, et al. The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study. Arthritis Res Ther. 2016;18(1):1\u201311.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"2558_CR17","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/acr.24025","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, et al. 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285\u201399.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"2558_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/ard-2022-222608","volume":"81","author":"D van der Heijde","year":"2022","unstructured":"van der Heijde D, Baraliakos X, Sieper J, et al. Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial. Ann Rheum Dis. 2022;81(11):1515\u201323.","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 73","key":"2558_CR19","first-page":"S136","volume":"30","author":"I Palla","year":"2012","unstructured":"Palla I, Trieste L, Tani C, et al. A systematic literature review of the economic impact of ankylosing spondylitis. Clin Exp Rheumatol. 2012;30(4 Suppl 73):S136\u201341.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2558_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40744-018-0124-4","volume":"5","author":"JA Walsh","year":"2018","unstructured":"Walsh JA, Song X, Kim G, et al. Healthcare utilization and direct costs in patients with ankylosing spondylitis using a large US administrative claims database. Rheumatol Ther. 2018;5(2):463\u201374.","journal-title":"Rheumatol Ther"},{"issue":"5","key":"2558_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.semarthrit.2014.10.009","volume":"44","author":"A Boonen","year":"2015","unstructured":"Boonen A, Sieper J, van der Heijde D, et al. The burden of non-radiographic axial spondyloarthritis. Semin Arthritis Rheum. 2015;44(5):556\u201362.","journal-title":"Semin Arthritis Rheum"},{"issue":"3 Suppl 2","key":"2558_CR22","first-page":"8","volume":"153","author":"L Pescitelli","year":"2018","unstructured":"Pescitelli L, Ricceri F, Prignano F. Hidradenitis suppurativa and associated diseases. G Ital Dermatol Venereol. 2018;153(3 Suppl 2):8\u201317.","journal-title":"G Ital Dermatol Venereol"},{"issue":"6","key":"2558_CR23","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/bjd.19435","volume":"183","author":"JR Ingram","year":"2020","unstructured":"Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol. 2020;183(6):990\u20138.","journal-title":"Br J Dermatol"},{"issue":"2","key":"2558_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40265-015-0516-5","volume":"76","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Prens EP. An update on medical treatment options for hidradenitis suppurativa. Drugs. 2016;76(2):215\u201329.","journal-title":"Drugs"},{"issue":"5","key":"2558_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaad.2019.08.089","volume":"82","author":"SR Goldburg","year":"2020","unstructured":"Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: current and emerging treatments. J Am Acad Dermatol. 2020;82(5):1061\u201382.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2558_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/bjd.17396","volume":"181","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis CC. The socioeconomic burden of hidradenitis suppurativa\/acne inversa. Br J Dermatol. 2019;181(1):7\u20138.","journal-title":"Br J Dermatol"},{"issue":"4","key":"2558_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jaad.2016.04.067","volume":"75","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Janse IC, van der Zee HH, et al. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): a cross-sectional reference study. J Am Acad Dermatol. 2016;75(4):755\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2558_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13075-019-1980-1","volume":"21","author":"HH Chen","year":"2019","unstructured":"Chen HH, Chao WC, Chen YH, et al. Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study. Arthritis Res Ther. 2019;21(1):196.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"2558_CR29","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729\u201335.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2558_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/pds.3447","volume":"22","author":"MM Asgari","year":"2013","unstructured":"Asgari MM, Wu JJ, Gelfand JM, et al. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996\u20132009. Pharmacoepidemiol Drug Saf. 2013;22(8):842\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"2558_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098024","volume":"9","author":"S Lofvendahl","year":"2014","unstructured":"Lofvendahl S, Theander E, Svensson A, et al. Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden\u2013a population-based register study. PLoS ONE. 2014;9(5): e98024.","journal-title":"PLoS ONE"},{"issue":"4","key":"2558_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","volume":"74","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Armstrong AW. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs. 2014;74(4):423\u201341.","journal-title":"Drugs"},{"issue":"Suppl 2","key":"2558_CR33","first-page":"ii14","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2558_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3899\/jrheum.150540","volume":"43","author":"JD Greenberg","year":"2016","unstructured":"Greenberg JD, Palmer JB, Li Y, et al. Healthcare resource use and direct costs in patients with ankylosing spondylitis and psoriatic arthritis in a large US cohort. J Rheumatol. 2016;43(1):88\u201396.","journal-title":"J Rheumatol"},{"issue":"12","key":"2558_CR35","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.37765\/ajmc.2021.88768","volume":"27","author":"P Prince","year":"2021","unstructured":"Prince P, Skornicki M, Suruki R, et al. Economic burden of joint analysis in psoriasis: US claims analysis. Am J Manag Care. 2021;27(12):e406\u201312.","journal-title":"Am J Manag Care"},{"issue":"9","key":"2558_CR36","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1080\/13696998.2017.1345749","volume":"20","author":"S Al Sawah","year":"2017","unstructured":"Al Sawah S, Foster SA, Goldblum OM, et al. Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis. J Med Econ. 2017;20(9):982\u201390.","journal-title":"J Med Econ"},{"issue":"9","key":"2558_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030579","volume":"9","author":"J Marvel","year":"2019","unstructured":"Marvel J, Vlahiotis A, Sainski-Nguyen A, et al. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open. 2019;9(9): e030579.","journal-title":"BMJ Open"},{"issue":"12","key":"2558_CR38","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3899\/jrheum.180802","volume":"45","author":"J Feld","year":"2018","unstructured":"Feld J, Chandran V, Gladman DD. What is axial psoriatic arthritis? J Rheumatol. 2018;45(12):1611\u20133.","journal-title":"J Rheumatol"},{"issue":"1","key":"2558_CR39","first-page":"142","volume":"33","author":"C Lopez-Medina","year":"2022","unstructured":"Lopez-Medina C, Ziade N. Axial disease in psoriatic arthritis: how can we define it, and does it have an impact on treatment? Med J Rheumatol. 2022;33(1):142.","journal-title":"Med J Rheumatol"},{"issue":"7","key":"2558_CR40","doi-asserted-by":"publisher","first-page":"S411","DOI":"10.1016\/j.jval.2022.04.638","volume":"25","author":"S Hopson","year":"2022","unstructured":"Hopson S, Gibbs L, Syed S, et al. EE390 Co-occurring chronic inflammatory diseases (CIDS): treatment patterns and healthcare resource utilization (HCRU) in the United States (US). Value Health. 2022;25(7):S411.","journal-title":"Value Health"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02558-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T01:11:48Z","timestamp":1694567508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02558-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2558"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02558-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}